International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Pustular Psoriasis

IMPROVE THE UNDERSTANDING OF THIS RARE AND LIFE-THREATENING DISEASE AND CONDUCT ACTIVITIES THAT WILL IMPROVE PATIENT TREATMENT

Project Description

IPC’s pustular psoriasis working group’s goal is to improve the understanding of this rare and life-threatening disease and conduct activities to improve patient treatment. Preliminary plans for 2022-2023 include: Reaching an international consensus on the classification of pustular psoriasis and related diseases; defining the objectives and addressing the feasibility of real-world data collection through international collaboration with pustular psoriasis clinical centers and laboratories; reaching a global consensus on pustular psoriasis scoring assessments; initiating intra-rater and inter-rater variability validation studies; and developing training modules on pustular scores and certification for clinical trial investigators.

Project Leaders

Siew Eng

Choon

,

MBBS, FRCP

Hospital Sultanah Aminah Johor Bahru, School of Medicine and Health Services, Monash University Malaysia
Johor
,
Malaysia

Chair

Hervé Bachelez Headshot

Hervé

Bachelez

,

MD, PhD

Hôpital Saint-Louis, Imagine Institute for Human Genetic Diseases, Paris Cité University
Paris
,
France

Co-Chair

Working Group Members

  • Jonathan Barker, United Kingdom
  • Francesca Capon, United Kingdom
  • Claudia de la Cruz, Chile
  • Johann Gudjonsson, United States
  • Akimichi Morita, Japan
  • Ricardo Romiti, Brazil

Support Our Work

Subscribe to the IPC Newsletter

We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.